首页 | 官方网站   微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   5482157篇
  免费   412768篇
  国内免费   18354篇
医药卫生   5913279篇
  2021年   58295篇
  2019年   60467篇
  2018年   78943篇
  2017年   60642篇
  2016年   67158篇
  2015年   79154篇
  2014年   113995篇
  2013年   180516篇
  2012年   161273篇
  2011年   172935篇
  2010年   138347篇
  2009年   135807篇
  2008年   156254篇
  2007年   168459篇
  2006年   174612篇
  2005年   168409篇
  2004年   168159篇
  2003年   157251篇
  2002年   145337篇
  2001年   218000篇
  2000年   216205篇
  1999年   192205篇
  1998年   79193篇
  1997年   72922篇
  1996年   70920篇
  1995年   66513篇
  1994年   60471篇
  1993年   56029篇
  1992年   143715篇
  1991年   138699篇
  1990年   134085篇
  1989年   129811篇
  1988年   119838篇
  1987年   117745篇
  1986年   111604篇
  1985年   108464篇
  1984年   86790篇
  1983年   75974篇
  1982年   54855篇
  1981年   50549篇
  1980年   47364篇
  1979年   77111篇
  1978年   59348篇
  1977年   51544篇
  1976年   48369篇
  1975年   49630篇
  1974年   56522篇
  1973年   54257篇
  1972年   50959篇
  1971年   47314篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
ABSTRACT

A monocausal bacteriological understanding of infectious disease orients tuberculosis control efforts towards antimicrobial interventions. A bias towards technological solutions can leave multistranded public health and social interventions largely neglected. In the context of globalising biomedical approaches to infectious disease control, this ethnography-inspired review article reflects upon the implementation of rapid diagnostic technology in low- and middle-income countries. Fieldwork observations in Vietnam provided a stimulus for a critical review of the global rollout of tuberculosis diagnostic technology. To address local needs in tuberculosis control, health managers in resource-poor settings are readily cooperating with international donors to deploy novel diagnostic technologies throughout national tuberculosis programme facilities. Increasing investment in new diagnostic technologies is predicated on the supposition that these interventions will ameliorate disease outcomes. However, suboptimal treatment control persists even when accurate diagnostic technologies are available, suggesting that promotion of singular technological solutions can distract from addressing systemic change, without which disease susceptibility, propagation of infection, detection gaps, diagnostic delays, and treatment shortfalls persist.  相似文献   
62.
63.
64.
65.
66.
67.
68.
69.
70.

Background

Nursing Home Compare (NHC) ratings, created and maintained by Medicare, are used by both hospitals and consumers to aid in the skilled nursing facility (SNF) selection process. To date, no studies have linked NHC ratings to actual episode-based outcomes. The purpose of this study was to evaluate whether NHC ratings are valid predictors of 90-day complications, readmission, and bundle costs for patients discharged to an SNF after primary total joint arthroplasty (TJA).

Methods

All SNF-discharged primary TJA cases in 2017 at a multihospital academic health system were queried. Demographic, psychosocial, and clinical variables were manually extracted from the health record. Medicare NHC ratings were then collected for each SNF. For patients in the Medicare bundle, postacute and total bundle cost was extracted from claims.

Results

Four hundred eighty-eight patients were discharged to a total of 105 unique SNFs. In multivariate analysis, overall NHC rating was not predictive of 90-day readmission/major complications, >75th percentile postacute cost, or 90-day bundle cost exceeding the target price. SNF health inspection and quality measure ratings were also not predictive of 90-day readmission/major complications or bundle performance. A higher SNF staffing rating was independently associated with a decreased odds for >75th percentile 90-day postacute spend (odds ratio, 0.58; P = .01) and a 90-day bundle cost exceeding the target price (odds ratio = 0.69; P = .02) but was similarly not predictive of 90-day readmission/complications.

Conclusion

Results of our study suggest that Medicare's NHC tool is not a useful predictor of 90-day costs, complications, or readmissions for SNFs within our health system.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号